DUALITY ADVISERS, LP - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
DUALITY ADVISERS, LP ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$380,706
-27.6%
10,676
-48.4%
0.05%
-20.0%
Q1 2023$525,678
-72.1%
20,696
-63.6%
0.06%
-70.7%
Q3 2022$1,881,000
+27.8%
56,917
+36.1%
0.20%
+41.4%
Q2 2022$1,472,000
+161.5%
41,815
+241.3%
0.14%
+141.7%
Q1 2022$563,00012,2510.06%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders